HOME >> BIOLOGY >> NEWS
Evidence for fat hormone target in brain

Nina Balthasar and her colleagues have presented direct evidence that the fat hormone leptin affects a specific type of target neurons in the brain -- a prime link in the brain's regulation of the body's energy balance.

Leptin is known to be produced by the body's fat tissues and to signal brain cells to reduce appetite and food intake and increase energy expenditures. Although researchers had produced indirect evidence that leptin affects the activity of particular neurons called POMC neurons in the brain, there had been no direct evidence of such an effect. The POMC neurons are found in the brain's hypothalamus, believed to be an important region for regulating the body's energy balance.

To directly demonstrate such an effect of leptin, Balthasar and her colleagues constructed a mutant mouse in which they could selectively knock out the receptors for leptin on the surface of POMC neurons. When they tested the effect of eliminating the receptors, they found that the mice had significantly increased body weight, due to an increase in fat mass.

Surprisingly, however, the researchers found that the mice gained less weight than would be expected if POMC neurons were the only targets of leptin. The researchers theorize that the reduction of POMC neuron activity due to lack of leptin signaling triggers compensatory mechanisms that reduce the impact on the animals' weight and energy metabolism. The researchers theorized that leptin might act to inhibit other neurons that, in turn, normally inhibit POMC neurons, thereby enhancing POMC activity.


'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
23-Jun-2004


Page: 1

Related biology news :

1. Evidence builds for potential new cancer drug target
2. Evidence for sympatric speciation by host shift in the sea
3. Evidence for the impact of climate change on deep-sea biodiversity
4. Evidence of nanobacterial-like structures found in human calcified arteries and cardiac valves
5. Evidence shows the heart has stem cells able to regenerate muscle tissue lost to disease, wear
6. Evidence for orangutan culture
7. Evidence suggests that standard smallpox vaccine offers long-term immunity
8. Evidence that adults stem cells differentiate like embryonic stem cells published in Nature
9. When Shewanella meets goethite: Evidence found of recognition between animate and inanimate objects
10. Evidence links protein damage to Parkinsons
11. Evidence suggests food preservatives may help prevent cavities

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... 08, 2020 , ... Overcoming Comparability Issues in Regenerative Medicines ... Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy , ... way to complete one? Will the study comply with all FDA requirements? Understanding ...
(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... monoclonal antibody development services, today announced that the company has received ISO9001:2015 ... the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... (PRWEB) , ... June 30, ... ... expert tissue data insights, today announced that the launch of a new ... along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight is ...
(Date:6/28/2020)... , ... June 25, 2020 , ... ... advance photodynamic therapy for treating cancer, today announced the company has entered a ... Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the premier provider ... Derek Fournier has been appointed CEO and President. Founder and former CEO, David ... , “DeCurtis Corporation has been on an incredible journey for the last twenty ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... innovative CNS therapies, today announced that it has filed an Investigational New Drug ... Phase 2b clinical trial of its lead drug candidate NBTX-001 in patients with ...
Breaking Biology Technology:
Cached News: